Amostras ambientais de Cryptococcus neoformans var. grubii na cidade de Santos, SP, Brasil by Soares, Maria Cecília Bianchi et al.
Rev. Inst. Med. trop. S. Paulo
47(1):31-36, January-February, 2005
(1) Microbiology and Immunology Section, Adolfo Lutz Institute, Santos, São Paulo, Brazil.
(2) Public Health Program, Universidade Católica de Santos, Santos, São Paulo, Brazil.
(3) Department of Microbiology, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, SP, Brazil.
Correspondence to: Sérgio Olavo Pinto da Costa, ICB II, USP, Av. Prof. Lineu Prestes 1374, 05508-900 São Paulo, SP, Brazil.Tel: + 55 11 30917294, Fax: +55 11 3091 7354. sopdcost@usp.br
ENVIRONMENTAL STRAINS OF Cryptococcus neoformans VARIETY grubii
IN THE CITY OF SANTOS, SP, BRAZIL
Maria Cecília Bianchi SOARES(1,2), Claudete Rodrigues PAULA(3), Amanda L.T. DIAS(3), Marcos Montani CASEIRO(2) & Sérgio Olavo Pinto da COSTA(2)
SUMMARY
This study involved a total of 116 samples, 79 taken from pigeon droppings and 37 of atmospheric air taken close to accumulations
of excrement. Cryptococcus neoformans var. grubii was isolated from 11 (13.9%) of these samples. Other species of Cryptococcus
were also isolated from these samples, such as C. albidus (12.6%) and C. laurentii (8.9%). C. neoformans was not isolated from
the air samples, though C. albidus (5.4%) was. All the strains of C. neoformans were found to belong to the A serotype (C.
neoformans var. grubii). In regard to the studies with the antifungal agents 5-fluorocytosine, fluconazole, itraconazole, amphotericin
B and voriconazole, by means of the microdilution method (EUCAST), we point out that one sample demonstrated resistance to
fluconazole, this being especially significant because this is an environmental strain.
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INTRODUCTION
Cryptococcus neoformans is an encapsulated yeast whose
teleomorphic state is a basidiomycete - Filobasidiella neoformans. It
is a cosmopolitan fungus frequently isolated from soil rich in organic
material, particularly pigeon droppings4,9. Nowadays, in respect to its
morphological, biochemical, immunological and epidemiological
characteristics, C. neoformans comprises three varieties: C. neoformans
var. neoformans, C. neoformans var. gattii and C. neoformans var.
grubii5.
Currently, the varieties of C. neoformans may be considered as
belonging to five serotypes: serotype A (var. grubii), serotype D and
AD (var. neoformans) and serotypes B and C (var. gattii = C.
bacillisporus)3,15,25.
It has been observed that this yeast may be present in a wide range
of locations such as old buildings, church towers, stables, basements,
sheds and various open-air public places, all of which could become
infective foci2,22,27.
C. neoformans can occur in low-frequency in the human species,
as part of the transitory microbiota18. Despite its saprophytic existence,
C. neoformans is able to infect and cause disease in immunocompetent
hosts (serotypes B and C) and, mainly, in immunocompromised patients
(serotypes A, D and AD)28. It can also infect other mammals, insects
and birds6.
In Brazil, Cryptococcus infection continues to be a lethal disease
related to Aids. One possible hypothesis can be the existence of
phenotypes that are resistant to antifungal therapy. New antifungal
agents have become available, resulting in a greater number of
therapeutic options and a demand for “in vitro” susceptibility testing12.
The Antifungal Susceptibility Testing Subcommittee of the
European Committee on Antibiotic Susceptibility Testing (AFST-
EUCAST) has developed a proposed standard broth microdilution
procedure for the determination of antifungal MICs of some species
of yeasts. This standard is based on the M27-A2 broth microdilution
reference procedure of the National Committee for Clinical Laboratory
Standards (NCCLS). It incorporates some modifications to allow the
automation of the susceptibility method and to permit the reduction of
the incubation period11.
It is generally held that the disease cryptococcosis is acquired from
the environment through the inhalation of yeasts and/or dried
basidiospores with incipient encapsulation, depending on the
immunological state of the host6.
It should be noted that the place studied here, Santos, is a city with
beaches attracting countless tourists, and has a significant number of
residents with Aids. The aim of this study was to verify the occurrence
of C. neoformans and its varieties in samples taken from the
environment, pigeon droppings and atmospheric air, determining the
prevailing serotype and the susceptibility to antifungal agents.
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MATERIALS AND METHODS
City studied: The city of Santos is located on the coast of the state
of São Paulo, 70 km from the city of São Paulo, and has a population
of about 410,000. To the north it borders on the counties of Santo
André, Mogi das Cruzes and Salesópolis; to the south, the Atlantic
Ocean and Santo Amaro Island; to the east, the county of Bertioga;
and to the west, the counties of Cubatão and São Vicente. The city
comprises an island with an area of 39.4 km2 and a mainland area of
231.6 km2. Its altitude is two meters, being predominantly flat but
circled by high hills. Its climate is tropical. Together with other counties,
it is part of the low coastland area denominated as the Baixada Santista.
It has served as a port city for a long time (since 1543), and at its
center there are historical constructions and monuments along with
many churches. As a coastal city, it contains a large number of beaches
and gardens. In all of these areas there can be found hundreds of pigeons,
in constant contact with the residents and tourists.
Environmental samples studied: The environmental samples were
collected from church towers, old buildings and dockside warehouses,
as well as streets downtown and along the beaches.
A total of 79 samples of pigeon droppings were collected along
with 37 samples of atmospheric air taken close to areas with
accumulations of excrement.
The pigeon excrement was collected in sterilized plastic bags, using
spatulas and brushes, from various sites within the urban area of the city.
Air contamination was verified at 37 locations by way of plates
exposed for 15 minutes.
Processing of the samples and yeast isolation: The samples were
processed less than 48 h after collection. Approximately 2 g of each
pigeon dropping sample was suspended in a flask containing 50 mL of
saline solution supplemented with chloramphenicol (0.1 g/L). After
vigorous shaking for five min, the flask was allowed to rest for 30 min
for phase separation.
A 2 mL volume of the supernatant was aspirated into test tubes for
centrifuging. The sediment was serially diluted until 10-3, and the pure
sample and its dilutions were cultured into Petri plates containing either
Sabouraud dextrose agar (Difco) and niger agar (Guizotia abysinica)14,
both supplemented with chloramphenicol (0.1g/L). The dishes were
placed into an incubator at 30 oC and observed daily for 15 days.
Identification of isolated yeasts: Selection was made of colonies
with a creamy white or creamy beige aspect grown in the Sabouraud
dextrose agar (Difco) or of dark-brown or black colonies grown in the
niger agar. These were examined by microscope for morphological
analysis, stained by a solution of cotton lactophenol blue and nigrosine
and transferred to tubes containing Sabouraud dextrose agar for
isolation. After growing, the colonies were cultured into tubes
containing niger agar for verification of the phenoloxidase activity,
and into Christensen’s urea agar8. Positive samples were identified
using a commercial yeast identification kit (API 20CAUX -
bioMéuriex). Culturing at 37 oC onto Sabouraud dextrose agar and in a
“mycosel” agar (Oxoid) were also carried out19.
Determination of the varieties isolated: The varieties of C.
neoformans isolated were determined by culturing in CGB medium
(L-canavanine, glycine and bromotimol blue)17. The control consisted
of standard strains of C. neoformans serotype A (ICB 163) and C.
neoformans serotype B (ICB 162).
Determination of serotypes: Serotyping of the C. neoformans
isolates was carried out using the Crypto Check kit (Iatron Laboratories,
Tokyo, Japan) with specific antisera. The standard strains were also
used18.
Assessment of the samples in regard to antifungal agents:
Susceptibility tests were run using five antifungal agents (5-
fluorocytosine - 5FC, fluconazole - FZ, itraconazole - IZ, amphotericin
B - AB, and voriconazole - VZ). The minimum inhibitory concentration
(MIC) was determined according to the standard technique established
by document M27-A224. These susceptibility tests included the standard
sample of C. neoformans var. neoformans ATCC 90012.
The modifications include the use of RPMI 1640 supplemented
with 2% glucose as the test medium, an inoculum size of 0.5 × 105 to
2.5 × 105 CFU/ml, flat-bottomed trays, and spectrophotometric reading
with a 50% inhibition endpoint for azole agents and flucytosine and
90% to azoles. In addition, a previous evaluation showed that MICs
obtained by the EUCAST broth microdilution method are in close
agreement with those obtained using the NCCLS reference procedure11.
Stock solutions were prepared in dimethyl sulfoxide, except
flucytosine, and fluconazole which was dissolved in sterile distilled
water. The assay medium was RPMI 1640 without sodium bicarbonate
and with L-glutamine buffered to pH 7.0 with 0.165 M
morpholinopropanesulfonic acid and supplemented with 18 g of glucose
per liter to reach a final concentration of 2% (RPMI-2% glucose; Oxoid
S.A., Madrid, Spain)10. Culture medium was prepared as a double-
strength solution and sterilized by filtration. Sterile plastic
microtitration plates containing flat-bottomed wells were utilized
(Corning Costar Europe, Badhoevedorp, The Netherlands). The plates
contained 100 µL of twofold serial dilutions of the antifungal drugs
per well. Two drug-free medium wells for sterility and growth controls
were employed. The final inoculum suspension contained between 0.5
× 105 and 2.5 × 105 CFU/mL, and an aliquot of 100 µL was added to
each well of the microdilution plate. The MIC endpoints (to inhibit
the growth at 50% to azoles and 5FC and 90% to AB) were determined
after incubation at 30 °C for 72 h and analyzed according some
breakpoints by NCCLS, 2002 or by some researches realized with drugs
that have not these values standardized yet by this committee. We
classified the strains in susceptible (S), susceptible-dose dependent
(S-DD), intermediate (I) or resistant (R) without necessarily a
correlation with clinical outcomes because for this are necessary studies
of correlation “in vitro” and “in vivo”. For FZ (S ≤ 8 µg/mL; 8 µg/mL
> SDD < 16 µg/mL; R ≥ 16 µg/mL); IZ, VZ (S ≤ 0.125 µg/mL; 0.25 µg/
mL ≥ SDD ≤ 0.5 µg/mL; R ≥ 1 µg/mL), 5FC (S ≤ 4 µg/mL; 8 µg/mL ≥
I ≤ 16 µg/mL; R ≥ 32 µg/mL); for AB (S < 2 µg/mL; R ≥ 2 µg/mL).
RESULTS
Of the 79 samples of pigeon droppings analyzed (Table 1), 11
(13.9%) were positive for C. neoformans; 10 (12.6%) samples were
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positive for C. albidus and 7 (8.9%) samples were positive for C.
laurentii.
Two samples of the total of 37 of atmospheric air were positive for
C. albidus (5.4%) (Table 1).
Of the 11 isolates of C. neoformans from pigeon excrement, four
were from church towers and seven from other places (Table 2).
All of the isolates of C. neoformans were found to belong to serotype
A (C. neoformans var. grubii).
In regard to susceptibility to the antifungal agents, one sample
(sample 2) presented resistance “in vitro” (MIC equal to 64 µg/mL) to
FZ. The results of the tests of susceptibility to antifungal agents are
presented in Tables 3 and 4.
Fluconazole: The MIC values for FZ ranged from 0.12 to 64 µg/
mL. Of the samples, 10 (91%) were susceptible and one (9%) was
resistant.
Itraconazole: The MIC values for IZ ranged from 0.015 to 0.06 µg/
mL. All the samples were susceptible to this drug.
Table 1
Yeast of the genus Cryptococcus isolated from environmental sources in the city of Santos, São Paulo state, Brazil
Yeasts isolated
Material C. neoformans C. albidus C. laurentii
Pos. Neg. Total Pos. Neg. Total Pos. Neg. Total
Excrement 11 68 79 10 69 79 7 72 79
Atmospheric air 0 37 37 2 35 37 0 37 7
Total 11 105 116 12 104 116 7 109 116
Table 2
Cryptococcus neoformans var. grubii isolated from pigeon excrement collected
in different locations, in the city of Santos, state of São Paulo, Brazil
Location Sample number
Collected Positive
Church towers 17 04 (23.5%)
Old buildings 15 00 (0%)
Health institutions 13 04 (30.7%)
Educational institutions 10 00 (0%)
Dockside warehouses 07 01 (14.3%)
Open-air public places 17 02 (11.8%)
(downtown or beachside
public squares/streets)
Total 79 11 (13.9%)
Table 3
Determination of the minimum inhibitory concentration (MIC)* (µg/mL) of
Cryptococcus neoformans samples isolated from pigeon excrement in the city
of Santos, state of São Paulo, Brazil
Sample 5FC FZ IZ VZ AB
1 0.5 2 0.015 0.015 1
2 16 64* 0.06 0.06 1
3 8 2 0.015 0.06 0.5
4 4 0.25 0.015 0.03 0.5
5 2 2 0.03 0.12 1
6 4 1 0.015 0.015 0.5
7 1 8 0.03 0.25 0.25
8 2 0.12 0.015 0.03 0.5
9 2 0.5 0.015 0.03 0.5
10 8 0.5 0.015 0.06 0.5
11 2 0.25 0.015 0.03 0.25
* resistant strain according to NCCLS, 2002; 5-FC = 5-flucytosine; FZ =
fluconazole; IZ = itraconazole; VZ = voriconazole; AB = amphotericin B
Table 4
Evaluation of the range MIC and the susceptibility profile of the isolates
Drug Isolate number Range MIC Susceptibility profile (%)
(µg/mL) Sa SDDb Ic Rd
FZ 11 0.12-64 91 - - 9
IZ 11 0.015-0.06 100 - - -
VZ 11 0.015-0.25 91 9 - -
5 FC 11 0.5-16 73 - 18 9
AB 11 0.25-1 100 - - -
a: susceptible; b: susceptible-dose dependent; c:intermediate; d: resistant
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Voriconazole: The MIC values for VZ ranged from 0.015 to 0.25
µg/mL. Ten (91%) of the samples were susceptible and one (9%)
presented a susceptibility dependent on dose.
5-Flucytosine: The MIC values for 5FC ranged from 0.5 to 16 µg/
mL. Eight (73%) of the samples were susceptible, two (18%) were
intermediate and one (9%) presented a susceptibility dependent on
dose.
Amphotericin B: The MIC values for AB ranged from 0.25 to 1.0
µg/mL. All of the samples were susceptible to this antifungal agent.
The results were interpreted according to document M 27 A224.
DISCUSSION
In a study carried out in 1994 in Mexico City, 251 samples of
pigeon excrement were analyzed and C. neoformans was isolated in
52 (20.7%). The greatest frequency of the isolation of this yeast was
from samples collected from public buildings (31.2%), followed by
churches (22%) and residences (13.3%)7. In another evaluation, 522
samples of pigeon excrement collected from 14 cities in Puerto Rico
were analyzed, of which 129 (24.7%) were positive for C. neoformans,
all of the isolates belonging to the variety neoformans29.
Some researchers carried out a study on 634 samples of pigeon
excrement collected in Turkey, in 1998, wherein C. neoformans was
isolated from only 29 (4.6%) of the samples. Most of the isolates were
obtained from samples collected from rooftops and pigeon nests32.
In the city of Rio de Janeiro, in 1993, 83 samples were studied
from the soil and 13.2% of them were positive for C. neoformans21.
In a study carried out in the city of São Paulo, it was encountered
positivity for this fungus in 21% of the places sampled from pigeon
droppings23, while in the city of Rio de Janeiro, it was found a positivity
of 31% in church towers with accumulation of pigeon excrement2.
The present study found positivity for C. neoformans in 13.9% of
the samples of pigeon droppings from church towers, old buildings
and open-air public places such as squares/parks and streets either
downtown or at the beachside.
The method used in the present study was the same as that used by
other authors2,23 and was unlike that used by others21 where samples
were taken only from the soil with pigeon excrements.
It is likely that the low rate of isolation of the fungus in the current
study is due to the low quantity of pigeon excrement available and the
high temperatures in the city of Santos during the summer, as well as
in other seasons. Cryptococcus does not grow at temperatures above
40 ºC and the excrement is moreover subject to leaching as well as
exposure to direct sunlight which can sterilize the sites contaminated
by this yeast16. The saprophytic sources of C. neoformans have been
researched in various parts of the world, but many questions concerning
the ecology of the fungus and the epidemiology of cryptococcosis
remain unresolved. In nature, excrement from pigeons and other birds,
as well as from soils contaminated by these materials, represents the
most significant source of C. neoformans var. neoformans, while C.
neoformans var. gattii has been isolated from vegetal fragments of
trees in some cryptococcosis-endemic areas13,20,30. In Brazil, both
varieties of the fungus are recognized as etiological agents of
cryptococcosis28.
The incidence of cryptococcosis has shown marked increases over
the last years. The number of reported cases of cryptococcosis has
risen to relatively high levels, and is considered the most frequent
systemic infection of opportunistic fungus in patients with Aids14.
Official data indicate that cryptococcosis occurs in 7% to 8% of the
patients with Aids in the United States, Europe and South America
and in up to 35% of these patients in Africa. In Brazil it occurs in
around 12% of these patients, with high rates of morbidity and
mortality26.
It was reported a 54% isolation rate for C. neoformans from dust
taken from houses occupied by Aids patients31.
One hundred and fifty four human residences were analyzed,
collecting 824 samples of dust from inside the houses and from the
soil and from bird excrement outside the houses. C. neoformans var.
grubii was isolated from 20 (13%) of the residences; more specifically,
from five of the 32 residences of Aids patients associated with
cryptococcosis, four (8.9%) of the 45 residences of Aids patients not
associated with cryptococcosis, and 11 (14.3%) of the 77 residences
of apparently healthy individuals. The authors found that the main
factor associated with household contamination by C. neoformans was
the presence of birds either within the house or in its environments27.
In Brazil, serotype A (C. neoformans var. grubii) is the prevailing
serotype found in environmental sources, such as pigeon excrement,
vegetable remains and atmospheric air, followed by serotype B25.
In the current study the 11 isolates belonged to serotype A, in
agreement with the literature review carried out by some authors
concerning the Brazilian isolates of C. neoformans25. This same serotype
A is also the most frequent in Brazilian clinical isolates (95%), followed
by serotype B (18.2%) as reported in the above-mentioned review.
The samples were analyzed in respect to their susceptibility profile
in regard to the five antifungal agents by way of the microdilution
method. One strain was resistant to fluconazole, revealing a primary
resistance to this drug; this finding is especially significant as this
isolate was from an environmental sample. Other studies involving
strains taken from the environment have warned about the resistance
to this azolic derivative that is often used in the treatment of
cryptococcal meningitis2. In respect to the other antifungal agents, all
of the samples were either susceptible (IZ and AB) or presented dose-
dependent susceptibility (VZ and 5FC).
So, this study has demonstrated that antifungal susceptibility results
obtained by using the EUCAST proposed standard reference procedure
are in close agreement with those achieved by the NCCLS M27A2
procedure. A great advantage of EUCAST standard is the reduction of
the incubation time needed to determine the MIC (from 72h to 48h
and 48 to 24 h ) and by this way, it may be more predictive of “in vivo”
outcome for isolates that give unclear visual endpoints at a longer
SOARES, M.C.B.; PAULA, C.R.; DIAS, A.L.T.; CASEIRO, M.M. & COSTA, S.O.P. - Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil. Rev.
Inst. Med. trop. S. Paulo, 47(1):31-36, 2005.
35
incubation time due to trailing growth. It is apparent that the trailing
phenomenon can be an important potential source of inaccuracy in
MIC determination in these cases1.
The results obtained provide a susceptibility profile of the
environmental isolates, nevertheless additional studies in relation to
the appropriate conditions for the realization of the tests and the
establishment of clinical correlations should be undertaken.
These findings reinforce the hypothesis that pigeons droppings are
an important factor of yeast infection in the urban environment,
underscoring the importance of our study for a city with a high Aids
rate, as is the case in Santos.
RESUMO
Amostras ambientais de Cryptococcus neoformans var. grubii na
cidade de Santos, SP, Brasil
Analisaram-se 116 amostras, sendo 79 de fezes de pombos e 37 de
ar atmosférico de regiões com acúmulo de fezes. Isolou-se
Cryptococcus neoformans var. neoformans de 11 (13.9%) destas
amostras. Outras espécies de Cryptococcus também foram isoladas
destas amostras tais como C. laurentii (8.9%) e C. albidus (12.6 %), o
qual também foi isolado de amostras do ar (5.4 %). Todas as amostras
de C. neoformans foram sorotipo A (C. neoformans var. grubii). Em
relação à avaliação do perfil de sensibilidade às drogas antifúngicas
(5-fluorocitosina, fluconazol, itraconazol, anfotericina B e voriconazol)
pelo método da microdiluição (EUCAST, 2002), destacou-se a presença
de uma amostra com valor de concentração inibitória mínima (CIM)
elevado para fluconazol, sendo de grande significância, uma vez tratar-
se de isolado ambiental.
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